Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin-Reference-Cited by-同舟云学术

Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin

Published:2007-04-12 Issue:1 Volume:61 Page:105-111
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Petrioli Roberto,Pascucci Alessandra,Francini Edoardo,Marsili Stefania,Sciandivasci Angela,Tassi Rossana,Civitelli Serenella,Tanzini Gabriello,Lorenzi Marco,Francini Guido

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-007-0454-3.pdf

Reference27 articles.

1. De Gramont A, Figer A, Seymour M, et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947

2. Andrè T, Boni C, Mounedji-Boudiaf L, Navarro M, et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351

3. Louvet C, Andre T, Tigaud JM, et al (2004) Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol 20:4543–4548

4. Al-Batran SE, Atmaca A, Hegewisch-Becker S, et al (2004) Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer. J Clin Oncol 22:658–663

5. Leong T (2005) Chemotherapy and radiotherapy in the management of gastric cancer. Curr Opin Gastroenterol 21:633–635

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study;Current Medical Research and Opinion;2024-06-22

2. Metabolomics analysis reveals characteristic metabolites in different levels of oxaliplatin‐induced neurotoxicity;Journal of Separation Science;2024-05-31

3. The Rate of Infusion Represents an Important Aspect of Administering Anticancer Agents;Risk Management and Healthcare Policy;2023-11

4. Chemotherapy-induced peripheral neurotoxicity: single-centre prospective study;BMJ Supportive & Palliative Care;2023-05-04

5. Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cells;Oncology Reports;2022-09-29